Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

General Medicine

Clinical Pharmacology

Efficacy of therapeutic-dose heparin for thromboprophylaxis in hospitalized patients with COVID-19

JAMA | Dec 10, 2021 Clinical Pharmacology

Treatment persistence to tolvaptan in patients with autosomal dominant polycystic kidney disease: A secondary use of data analysis of patients in the IMADJIN dataset

BMC Nephrology | Dec 10, 2021 Clinical Pharmacology

Efficacy of heparinoid cream containing pseudo-ceramide for remission of atopic dermatitis

Clinical, Cosmetic and Investigational Dermatology | Dec 10, 2021 Clinical Pharmacology

A multicenter, randomized, parallel‐group, double‐blind, vehicle‐controlled and open‐label, active‐controlled study (vs amorolfine 5%), to evaluate the efficacy and safety of terbinafine 10% nail lacquer in the treatment of onychomycosis

Mycoses | Dec 09, 2021 Clinical Pharmacology

Long-term safety and efficacy of imeglimin as monotherapy or in combination with existing antidiabetic agents in Japanese patients with type 2 diabetes (TIMES 2): A 52-week open-label, multicenter phase 3 trial

Diabetes, Obesity and Metabolism | Dec 09, 2021 Clinical Pharmacology

Glycemic variability in patients with type 2 diabetes mellitus treated with dulaglutide, with and without concomitant insulin: Post hoc analyses of randomized, clinical trials

Diabetes, Obesity and Metabolism | Dec 09, 2021 Clinical Pharmacology

Adjuvant chemotherapy use and survival outcomes in older adults with pancreatic adenocarcinoma

JAMA | Dec 08, 2021 Clinical Pharmacology

The Alaska Native/American Indian experience of hepatitis C treatment with sofosbuvir-based direct-acting antivirals

PLoS Neglected Tropical Diseases | Dec 08, 2021 Clinical Pharmacology

Safety and efficacy of mevidalen in Lewy body dementia: A phase 2, randomized, placebo‐controlled trial

Movement Disorders | Dec 08, 2021 Clinical Pharmacology

What represents treatment efficacy in long-term studies of gout flare prevention?: An interview study of people with gout

The Journal of Rheumatology | Dec 08, 2021 Clinical Pharmacology

« Prev 1 … 14 15 16 17 18 … 338 Next »

Efficacy of therapeutic-dose heparin for thromboprophylaxis in hospitalized patients with COVID-19

Treatment persistence to tolvaptan in patients with autosomal dominant polycystic kidney disease: A secondary use of data analysis of patients in the IMADJIN dataset

Efficacy of heparinoid cream containing pseudo-ceramide for remission of atopic dermatitis

A multicenter, randomized, parallel‐group, double‐blind, vehicle‐controlled and open‐label, active‐controlled study (vs amorolfine 5%), to evaluate the efficacy and safety of terbinafine 10% nail lacquer in the treatment of onychomycosis

Long-term safety and efficacy of imeglimin as monotherapy or in combination with existing antidiabetic agents in Japanese patients with type 2 diabetes (TIMES 2): A 52-week open-label, multicenter phase 3 trial

Glycemic variability in patients with type 2 diabetes mellitus treated with dulaglutide, with and without concomitant insulin: Post hoc analyses of randomized, clinical trials

Adjuvant chemotherapy use and survival outcomes in older adults with pancreatic adenocarcinoma

The Alaska Native/American Indian experience of hepatitis C treatment with sofosbuvir-based direct-acting antivirals

Safety and efficacy of mevidalen in Lewy body dementia: A phase 2, randomized, placebo‐controlled trial

What represents treatment efficacy in long-term studies of gout flare prevention?: An interview study of people with gout

Micronutrient Deficiencies in The Modern Diet: Causes & Correction

Age Related Macular Degeneration

Managing Polypharmacy in Elderly Patients

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Efficacy of therapeutic-dose heparin for thromboprophylaxis in hospitalized patients with COVID-19

Treatment persistence to tolvaptan in patients with autosomal dominant polycystic kidney disease: A secondary use of data analysis of patients in the IMADJIN dataset

Efficacy of heparinoid cream containing pseudo-ceramide for remission of atopic dermatitis

A multicenter, randomized, parallel‐group, double‐blind, vehicle‐controlled and open‐label, active‐controlled study (vs amorolfine 5%), to evaluate the efficacy and safety of terbinafine 10% nail lacquer in the treatment of onychomycosis

Long-term safety and efficacy of imeglimin as monotherapy or in combination with existing antidiabetic agents in Japanese patients with type 2 diabetes (TIMES 2): A 52-week open-label, multicenter phase 3 trial

Glycemic variability in patients with type 2 diabetes mellitus treated with dulaglutide, with and without concomitant insulin: Post hoc analyses of randomized, clinical trials

Adjuvant chemotherapy use and survival outcomes in older adults with pancreatic adenocarcinoma

The Alaska Native/American Indian experience of hepatitis C treatment with sofosbuvir-based direct-acting antivirals

Safety and efficacy of mevidalen in Lewy body dementia: A phase 2, randomized, placebo‐controlled trial

What represents treatment efficacy in long-term studies of gout flare prevention?: An interview study of people with gout

Micronutrient Deficiencies in The Modern Diet: Causes & Correction

Age Related Macular Degeneration

Managing Polypharmacy in Elderly Patients

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Select Specialty

Select Topic